You are here

Sanofi

Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic

Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic

BioSpace

pharma industry

CRISPR Therapeutics

Sana Biotechnology

Flag link:

Sanofi Streamlines Pipeline Focus While Looking Ahead to a Post-COVID-19 World

Sanofi Streamlines Pipeline Focus While Looking Ahead to a Post-COVID-19 World

BioSpace

Flag link:

Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts

Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts

BioSpace

Flag link:

Merck treads on Sanofi, Regeneron's turf with Keytruda's latest skin cancer OK

Merck treads on Sanofi, Regeneron's turf with Keytruda's latest skin cancer OK

Fierce Pharma

squamous cell carcinoma

Flag link:

Sanofi's fight for a better research reputation

Sanofi's fight for a better research reputation

BioPharma Dive

immune disorders

Flag link:

Sanofi’s third Translate collaboration sees big bucks at last

Sanofi’s third Translate collaboration sees big bucks at last

EP Vantage

Flag link:

Third-quarter events to watch for large drug makers

Third-quarter events to watch for large drug makers

EP Vantage

Bristol-Myers Squibb

Flag link:

Sanofi, Regeneron Win China Approval For Dupixent Dermatitis Drug

Sanofi, Regeneron Win China Approval For Dupixent Dermatitis Drug

Yahoo/SmarterAnalyst

atopic dermatitis

Flag link:

Amicus shares surge as Sanofi struggles to raise a cheer for mixed pivotal data for a PhIII contender — and analysts blow a raspberry

Amicus shares surge as Sanofi struggles to raise a cheer for mixed pivotal data for a PhIII contender — and analysts blow a raspberry

Endpoints

Amicus Therapeutics

clinical trials

Avalglucosidase alfa

Flag link:

Sanofi pumps $554M into new vaccine manufacturing facility in eastern France

Sanofi pumps $554M into new vaccine manufacturing facility in eastern France

Fierce Pharma

drug manufacturing

Flag link:

ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar

ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar

Fierce Pharma

type 2 diabetes

Flag link:

ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2

ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2

Fierce Pharma

Flag link:

Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus

Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus

Motley Fool

Flag link:

AAD 2020 – Leo’s eczema wildcard proves tame

AAD 2020 – Leo’s eczema wildcard proves tame

EP Vantage

atopic dermatitis

Flag link:

After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug

After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug

BioSpace

Denali Therapeutics

Alzheimer's disease

clinical trials

Flag link:

Sanofi sharpens focus on bispecifics, and China, with Alphamab deal

Sanofi sharpens focus on bispecifics, and China, with Alphamab deal

Endpoints

Alphamab Oncology

bispecific antibodies

Flag link:

The coronavirus vaccine frontrunners have emerged. Here's where they stand

The coronavirus vaccine frontrunners have emerged. Here's where they stand

BioPharma Dive

Moderna Therapeutics

Cansino Biologics

Oxford BioMedica

Flag link:

After 11 years, Sanofi kicks backs the rights to unwanted gene therapies to Oxford Biomedica

After 11 years, Sanofi kicks backs the rights to unwanted gene therapies to Oxford Biomedica

Fierce Biotech

Oxford BioMedica

Flag link:

Is Moderna Really the Leader in the COVID-19 Vaccine Race?

Is Moderna Really the Leader in the COVID-19 Vaccine Race?

Motley Fool

Moderna Therapeutics

Flag link:

Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project

Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project

Fierce Pharma

Flag link:

Pages